- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02460718
ENCOURAGE: Evaluating Community Peer Advisors and Diabetes Outcomes in Rural Alabama (ENCOURAGE)
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The purpose of this project was to provide robust evidence on the effectiveness of a peer support intervention in improving diabetes outcomes by conducting a group-randomized, controlled implementation trial of a volunteer peer support intervention.
The study had three specific aims:
Aim 1. In Phase I (months 0-8), to perform a qualitative needs assessment with peer advisors and health care providers to inform peer advisor roles and responsibilities (i.e., the intervention) and peer advisor recruitment strategies, curriculum and training; and patient recruitment plans.
Aim 2. Also in Phase I, to pilot our collaboratively developed intervention and, based on pilot test results, to recruit and train peer advisors for the intervention, and begin patient recruitment.
Aim 3. In Phase II (months 9-32), conduct the group randomized implementation trial and evaluate it using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- 19 or older in age, diagnosed with diabetes, under the care of a doctor
Exclusion Criteria:
- not community dwelling, less than 19 years old, pregnant, end-stage medical conditions with limited life expectancy, no access to telephone, does not speak english
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: control group
Participants received 1-hour group diabetes education class covering diabetes basics, healthy eating, stress reduction, physical activity, social support, and how to get the most out of their doctors visit.
Participants also received a diabetes report card showing their Hba1c, blood pressure, ldl cholesterol, and body weight.
|
|
|
Eksperimentel: Encourage study
Participants in the intervention arm were paired with a peer coach, interacting by telephone weekly for the first 8 weeks and then monthly for a total of 10 months. Participants also received 1-hour group diabetes education class covering diabetes basics, healthy eating, stress reduction, physical activity, social support, and how to get the most out of their doctors visit. Participants also received a diabetes report card showing their Hba1c, blood pressure, ldl cholesterol, and body weight. |
This intervention tested the effects of a peer coaching program plus brief diabetes education versus brief diabetes education alone on diabetes outcomes.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Glycated hemoglobin (A1c)
Tidsramme: Change in A1c in 12 months
|
fingerstick, point-of-care a1c test
|
Change in A1c in 12 months
|
|
Blood pressure
Tidsramme: Change in blood pressure measure in 12 months
|
Measured using digital automated blood pressure monitor
|
Change in blood pressure measure in 12 months
|
|
LDL cholesterol
Tidsramme: Change in LDL cholesterol in 12 month
|
measured using finger stick, spectrophotometer to measure LDL cholesterol
|
Change in LDL cholesterol in 12 month
|
|
diabetes self-care behaviors questionnaire
Tidsramme: Change in diabetes self-care behaviors at 12 months
|
aspects of diabetes self-management such as taking medications as directed, self-report of exercise, and eating behaviors
|
Change in diabetes self-care behaviors at 12 months
|
|
depressive symptoms
Tidsramme: change in depressive symptoms at 12 months
|
self-report using Patient Health Questionnaire 8 (PHQ8)
|
change in depressive symptoms at 12 months
|
|
quality of life
Tidsramme: Change in quality of life measures at 12 months
|
self-report using Short form-1 (SF1), and Euroquol (EQ-5D)
|
Change in quality of life measures at 12 months
|
|
patient activation
Tidsramme: change in patient activation in 12 months
|
self-report using the 13 item Patient Activation Measure (PAM13)
|
change in patient activation in 12 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
body mass index
Tidsramme: change in BMI in 12 months
|
weight measured using digital scale, height measured using stadiometer
|
change in BMI in 12 months
|
|
diabetes knowledge
Tidsramme: change in diabetes knowledge in 12 months
|
assessed using the Spoken Knowledge in Low Literacy in Diabetes Scale
|
change in diabetes knowledge in 12 months
|
|
trust in physicians
Tidsramme: change in trust in physicians in 12 months
|
assessed using the Trust in Physicians Scale
|
change in trust in physicians in 12 months
|
|
composite measure of healthcare utilization
Tidsramme: Change in health care utilization in 12 months
|
self-report by participant, number of times utilized healthcare services
|
Change in health care utilization in 12 months
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- T0808270039
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Diabetes mellitus
-
State University of New York at BuffaloMedical University of South CarolinaAfsluttetDiabetes mellitus | Type 2 diabetes mellitus | Voksen-debuterende diabetes mellitus | Ikke-insulinafhængig diabetes mellitus | Ikke-insulinafhængig diabetes mellitus, type IIForenede Stater
-
Meir Medical CenterAfsluttetDiabetes mellitus type 2 | Diabetes mellitus, ikke-insulinafhængig | Diabetes mellitus, om oral hypoglykæmisk behandling | Voksen type diabetes mellitusIsrael
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.AfsluttetDiabetes mellitus, type 1 | Type 1 diabetes | Diabetes type 1 | Type 1 diabetes mellitus | Autoimmun diabetes | Diabetes mellitus, insulinafhængig | Juvenil-Debut Diabetes | Diabetes, autoimmun | Insulinafhængig diabetes mellitus 1 | Diabetes mellitus, insulinafhængig, 1 | Diabetes mellitus, skør | Diabetes Mellitus... og andre forholdForenede Stater
-
SanofiAfsluttetType 1-diabetes mellitus-type 2-diabetes mellitusUngarn, Den Russiske Føderation, Tyskland, Polen, Japan, Forenede Stater, Finland
-
Medtronic MiniMed, Inc.RekrutteringType 2 diabetes mellitus | Type 1 diabetes mellitusForenede Stater, Australien, New Zealand
-
Peking Union Medical College HospitalUkendtType 2 diabetes mellitus | Type 1 diabetes mellitus | Svangerskabsdiabetes mellitus | Pancreatogen diabetes mellitus | Prægestationsdiabetes mellitus | Diabetespatienter i perioperativ periodeKina
-
Guang NingRekrutteringType 2 diabetes mellitus | Type 1 diabetes mellitus | Monogenetisk diabetes | Pancreatogen diabetes | Lægemiddel-induceret diabetes mellitus | Andre former for diabetes mellitusKina
-
Hoffmann-La RocheRoche DiagnosticsAfsluttetDiabetes mellitus type 2, diabetes mellitus type 1Tyskland
-
Insulet CorporationRekrutteringType 2 diabetes mellitus | Type 1 diabetes mellitusForenede Stater
-
State University of New York at BuffaloMedical University of South Carolina; National Institute of Diabetes and...AfsluttetDiabetes mellitus, type 2 | Diabetes mellitus, type II | Diabetes mellitus, voksendebut | Diabetes mellitus, ikke-insulinafhængig | Diabetes mellitus, ikke-insulinafhængigForenede Stater
Kliniske forsøg med ENCOURAGE Study
-
Radicle ScienceAfsluttetKognitiv funktionForenede Stater
-
Verily Life Sciences LLCAfsluttet
-
Poitiers University HospitalRekrutteringDiabetes | Hypoxi | Diabetisk nyresygdom | Diabetiske nefropatier | Sund frivilligFrankrig
-
Radicle ScienceAfsluttetKognitiv funktionForenede Stater
-
Tampere University HospitalAfsluttet
-
University of MichiganAfsluttet
-
University of MichiganAfsluttet
-
Radicle ScienceAfsluttetSmerte | Neuropatisk smerte | Nociceptiv smerteForenede Stater
-
M2 IngredientsRekrutteringKognitiv tilbagegangForenede Stater
-
Scion NeuroStimAfsluttetParkinsons sygdom | Parkinsons sygdom og ParkinsonismeForenede Stater